HomeHRTX • NASDAQ
add
Heron Therapeutics Inc
Previous close
$2.55
Day range
$2.50 - $2.63
Year range
$0.50 - $3.22
Market cap
383.34M USD
Avg Volume
1.97M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 34.23M | 14.00% |
Operating expense | 23.32M | -8.55% |
Net income | -10.72M | 46.03% |
Net profit margin | -31.33 | 52.65% |
Earnings per share | -0.07 | 58.82% |
EBITDA | -9.00M | 36.42% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 80.41M | -5.24% |
Total assets | 222.51M | -11.33% |
Total liabilities | 256.48M | 8.05% |
Total equity | -33.97M | — |
Shares outstanding | 150.33M | — |
Price to book | -11.09 | — |
Return on assets | -10.76% | — |
Return on capital | -16.32% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -10.72M | 46.03% |
Cash from operations | 2.46M | 106.54% |
Cash from investing | -8.84M | -537.21% |
Cash from financing | 199.00K | -54.67% |
Net change in cash | -6.18M | 82.37% |
Free cash flow | 5.65M | 119.52% |
About
Founded
1983
Headquarters
Website
Employees
126